Molins PLC
24 April 2002
MOLINS PLC
Annual General Meeting
At today's AGM, Peter Byrom, Chairman of Molins, said:
'Trading this year started well and is continuing to meet our expectations.
'We are committed to providing our customers with continued improvements in
products and services. The acquisition in February this year of Arista
Laboratories, an independent smoke constituent analytical facility, was in line
with our strategy of making incremental investments to extend our existing
services. Arista is being integrated into the group and is on track to achieve
significant growth in revenues compared with 2001.
'We have recently launched important new product upgrades in the tobacco
machinery division and plan further new launches over the next few months.
'Despite markets that are still difficult, having structured our packaging
machinery division to balance capacity more closely with demand, the division is
trading ahead of last year and is profitable at current levels of business.
'We continue to evaluate other acquisition and investment opportunities and
remain confident in the future outlook for the company.'
Enquiries:
Molins PLC
Tel: 01908 219000
Peter Byrom, Chairman
David Cowen, Group Finance Director
Issued by:
Citigate Dewe Rogerson
Tel: 020 7638 9571
Margaret George
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.